2-methyl-3-hydroxybutyricacidemia is a rare inherited metabolic disease. Your body cannot properly break down the amino acid isoleucine and cannot use ketone bodies well. Ketone bodies are emergency fuels that your body makes when you do not eat for a long time or during illness. Because of the enzyme defect, toxic acids build up in blood and urine. This can cause sudden attacks of ketoacidosis with vomiting, fast breathing, sleepiness, and even coma. The disease is caused by harmful changes (mutations) in the ACAT1 gene. It is passed down in an autosomal recessive way. Babies are often healthy between attacks, but stress, fasting, or infection can trigger severe episodes. MedlinePlus+2MedlinePlus+2

2-methyl-3-hydroxybutyricacidemia is a genetic, X-linked neurometabolic disease. A change (mutation) in the HSD17B10 gene harms a mitochondrial enzyme, so the body struggles to fully break down the amino acid isoleucine and to maintain healthy mitochondrial function. Babies may look well first, then lose skills (developmental regression). Common problems include low muscle tone, seizures, feeding difficulty, vision/hearing loss, and sometimes heart muscle weakness. The condition is often worse in males. Lab tests show high 2-methyl-3-hydroxybutyric acid and tiglylglycine. MedlinePlus+2PubMed Central+2

Other names: HSD10 disease; HSD17B10 deficiency; 2-methyl-3-hydroxybutyryl-CoA dehydrogenase deficiency; 2-methyl-3-hydroxybutyric aciduria. orpha.net+1

During attacks, the urine shows high levels of 2-methyl-3-hydroxybutyrate and tiglylglycine. Doctors look for this pattern to make the diagnosis. orpha.net+2orpha.net+2

Other names

• Beta-ketothiolase deficiency

• BKT deficiency

• ACAT1 deficiency

• Mitochondrial acetoacetyl-CoA thiolase deficiency

• 2-methyl-3-hydroxybutyric acidemia / aciduria (older terms) MedlinePlus+1

Types

There is no single official “type” system, but doctors see common patterns:

1. Intermittent ketoacidotic type
   Most children are well between episodes. Attacks occur with illness or fasting. Urine organic acids show the classic markers during attacks. jpedres.org

2. Early-infantile type
   First crisis appears in the first 1–2 years of life, sometimes earlier, and may be severe. MedlinePlus

3. Recurrent febrile-triggered type
   Crises recur mainly with fever, vomiting, or dehydration. newbornscreening.hrsa.gov

4. Neurologic-complication type
   Some children develop movement problems or basal-ganglia injury after severe crises (sometimes called “metabolic stroke”). PubMed

5. Genotype-severity spectrum
   Different ACAT1 mutations cause a range of enzyme activity and symptom severity. Over 100 variants have been reported. MedlinePlus

Causes

Root cause

1. ACAT1 gene mutations (autosomal recessive)—the single true cause of the disorder; the enzyme beta-ketothiolase does not work well, so isoleucine and ketone use are impaired. MedlinePlus+1

Common triggers that precipitate ketoacidosis in affected people

2. Fasting—long gaps without food push the body to make ketones, stressing the blocked pathway. newbornscreening.hrsa.gov

3. Fever—raises energy needs and increases catabolism. newbornscreening.hrsa.gov

4. Viral or bacterial infection—illness increases breakdown of body stores. newbornscreening.hrsa.gov

5. Vomiting with poor intake—causes both fasting and dehydration. MedlinePlus

6. Dehydration—worsens acidosis and kidney handling of organic acids. MedlinePlus

7. High-protein load (rich in isoleucine)—adds more substrate to the blocked pathway. MedlinePlus

8. Post-operative stress—surgery increases catabolic hormones. (General principle in organic acidemias.) MDPI

9. Prolonged strenuous exercise without adequate carbs—can mimic fasting. (Inferred from ketone physiology.) MDPI

10. Crash dieting—rapid fat breakdown increases ketone production. MDPI

11. Poorly treated gastroenteritis—combines infection, fasting, and dehydration. newbornscreening.hrsa.gov

12. Delayed treatment of intercurrent illness—late glucose/fluids allows acidosis to deepen. newbornscreening.hrsa.gov

13. Certain medications that suppress appetite or cause vomiting—indirect trigger through reduced intake. (General metabolic care principle.) MDPI

14. Low-carb ketogenic dieting—pushes heavy ketone production and is risky in ketolysis defects. MedlinePlus

15. Prolonged overnight fasting in toddlers—common setting for first crisis. MedlinePlus

16. Untreated hypoglycemia—drives ketone formation and stress hormones. newbornscreening.hrsa.gov

17. Heat stress with poor intake—adds dehydration to fasting physiology. MDPI

18. Delayed diagnosis—repeated unrecognized crises cause cumulative injury. ScienceDirect

19. Missed sick-day plan—lack of emergency glucose/fluids during illness. newbornscreening.hrsa.gov

20. Interrupted maintenance diet—inconsistent carbohydrate intake increases risk. newbornscreening.hrsa.gov

Symptoms

Symptoms often appear during an acute attack; between attacks, the child may seem normal.

1. Vomiting—often the first sign during illness. MedlinePlus

2. Poor feeding / refusal to eat—worsens fasting. newbornscreening.hrsa.gov

3. Lethargy or unusual sleepiness—brain effects of acidosis. MedlinePlus

4. Rapid, deep breathing (Kussmaul breathing)—body tries to blow off acid. ispae-jped.com

5. Dehydration—dry mouth, sunken eyes, less urine. MedlinePlus

6. Fever—common trigger and sign of infection. newbornscreening.hrsa.gov

7. Fruity breath—from ketones. ispae-jped.com

8. Irritability or confusion—due to metabolic imbalance. MedlinePlus

9. Seizures—especially in severe acidosis or low sugar. MedlinePlus

10. Coma—in untreated or severe cases. MedlinePlus

11. Poor weight gain or failure to thrive—in some children with frequent crises. ScienceDirect

12. Developmental delay after severe crises—injury from repeated decompensation. ScienceDirect

13. Movement problems after “metabolic stroke”—dystonia or choreoathetoid movements can occur. PubMed

14. Headache or abdominal pain—nonspecific stress signs in children. ScienceDirect

15. No symptoms between episodes—many children are entirely well when stable. jpedres.org

Diagnostic tests

A) Physical Exam (what a clinician looks for)

1. General assessment and vital signs
   The doctor checks temperature, heart rate, breathing rate, and blood pressure. Fever, fast breathing, and dehydration are common in attacks. These signs help decide how urgent the situation is and whether the child needs IV fluids and glucose. newbornscreening.hrsa.gov

2. Hydration status
   Dry mouth, low tears, and delayed capillary refill suggest dehydration, which worsens acidosis. Correcting fluids is part of emergency care, and the exam guides how fast to replace fluids. newbornscreening.hrsa.gov

3. Neurologic exam
   Doctors look for alertness, tone, reflexes, and seizures. Abnormal findings point to brain stress from acidosis or hypoglycemia and help triage to intensive care if needed. PubMed

4. Growth and development review
   History and observation of milestones show whether previous crises have left delays. This helps plan long-term supports like therapy. ScienceDirect

B) Manual / bedside tests (quick checks)

5. Capillary glucose (finger-stick)
   Hypoglycemia can coexist with ketoacidosis. A quick bedside glucose guides immediate dextrose therapy. newbornscreening.hrsa.gov

6. Urine ketone strip
   A simple dipstick shows ketones during attacks. In BKT deficiency, ketones are often present, but the exact pattern needs full lab analysis. ispae-jped.com

7. Point-of-care blood gas / lactate
   Bedside analyzers give pH and bicarbonate to grade acidosis and track response to treatment. ispae-jped.com

C) Laboratory and pathological tests (core of the diagnosis)

8. Urine organic acids by GC-MS
   This is the key test. It shows high 2-methyl-3-hydroxybutyrate and tiglylglycine (and sometimes 2-methylacetoacetate). The pattern during a crisis is highly suggestive of BKT deficiency. orpha.net+2orpha.net+2

9. Plasma acylcarnitine profile (tandem MS)
   C5:1 and related markers can be abnormal; useful in newborn screening and acute workups. PubMed Central

10. Comprehensive metabolic panel and electrolytes
    Shows anion-gap metabolic acidosis, dehydration, and kidney function. This helps guide fluids and bicarbonate therapy. ispae-jped.com

11. Arterial or venous blood gas
    Confirms the degree of acidosis (low pH, low bicarbonate) and tracks improvement. ispae-jped.com

12. Plasma ammonia
    Elevated ammonia suggests severe catabolic stress or other metabolic disorders; helps in differential diagnosis. MDPI

13. Plasma amino acids
    Assesses isoleucine metabolites and helps rule out other aminoacidopathies. It complements urine organic acids. MDPI

14. Genetic testing of ACAT1
    Sequencing confirms the diagnosis and allows family testing. Over 100 variants are known. MedlinePlus+1

15. Enzyme assay in cultured fibroblasts or leukocytes
    Measures beta-ketothiolase activity directly and can confirm a functional defect when genetics are inconclusive. ispae-jped.com

16. Newborn screening follow-up
    If the screen is flagged, targeted organic acid and acylcarnitine testing, plus genetics, are done to confirm or exclude the condition. newbornscreening.hrsa.gov

17. Urine tiglylglycine quantitation
    Tiglylglycine is a useful marker and part of the typical pattern in BKT deficiency. MarkerDB

18. Repeat urine organic acids when well vs. sick
    Profiles may be only mildly abnormal when the child is well; testing during illness often reveals the classic peaks. PubMed

D) Electrodiagnostic tests

19. Electroencephalogram (EEG)
    Used if the child has seizures or altered consciousness. Helps detect ongoing seizure activity and guide antiepileptic treatment. ScienceDirect

E) Imaging tests

20. Brain MRI (with attention to basal ganglia)
    In severe crises, MRI may show pallidal or other basal-ganglia injury—sometimes called a metabolic “stroke.” This explains movement symptoms after recovery. PubMed

Non-pharmacological treatments (therapies & others)

1. Metabolic “sick-day” plan & emergency letter.
   Plan ahead for fevers, vomiting, or poor intake with rapid access to high-glucose fluids and hospital protocols. Purpose: prevent catabolism and decompensation. Mechanism: continuous carbohydrate supply suppresses breakdown of body protein/fat that can worsen organic acid buildup. PubMed Central+1

2. Frequent, evenly spaced feeds; avoid prolonged fasting.
   Small, regular meals or nocturnal feeds keep energy steady. Purpose: reduce risk of metabolic crisis. Mechanism: steady glucose reduces ketogenesis and amino-acid catabolism. PubMed Central+1

3. Hospital hydration with dextrose during illness.
   In intercurrent illness, IV 10% dextrose (with electrolytes) is often used per metabolic protocols. Purpose: reverse dehydration and provide calories. Mechanism: IV glucose drives anabolism and corrects hypoglycemia/acidosis. newenglandconsortium.org

4. Dietitian-guided protein/branched-chain amino acid management.
   Any protein or isoleucine restriction must be specialist-supervised; evidence for benefit in HSD10 disease is lacking. Purpose: maintain growth while avoiding deficiency. Mechanism: individualized targets minimize unnecessary precursor load without provoking catabolism. SpringerLink

5. Physiotherapy for hypotonia/spasticity.
   Goal-directed stretching, positioning, and strengthening optimize function and prevent contractures. Purpose: preserve mobility and comfort. Mechanism: repetitive practice supports neuro-motor patterns and joint range. MedlinePlus

6. Occupational therapy (OT).
   Adaptive seating, hand-use training, and daily-living aids. Purpose: support independence and caregiver safety. Mechanism: task-specific training and equipment reduce energy cost of activities. MedlinePlus

7. Speech-language therapy (communication).
   Early augmentative/alternative communication supports language access when speech is limited. Purpose: maintain social interaction and learning. Mechanism: alternative modalities bypass motor/speech constraints. MedlinePlus

8. Swallow therapy & safe feeding strategies.
   Positioning, texture modification, and pacing to reduce aspiration. Purpose: protect lungs and ensure nutrition. Mechanism: compensatory techniques improve airway protection during swallowing. MedlinePlus

9. Enteral feeding via gastrostomy (G-tube) when needed.
   For severe dysphagia or poor intake. Purpose: reliable nutrition/med delivery. Mechanism: direct gastric access bypasses unsafe oral feeding. MedlinePlus

10. Hearing assessment and early devices.
    Newborn/early hearing screening, then hearing aids or implants as indicated. Purpose: protect language development. Mechanism: amplification or cochlear stimulation improves access to sound. MedlinePlus+1

11. Cochlear implant evaluation (if severe sensorineural loss).
    Consider for profound loss unhelped by hearing aids. Purpose: enable sound perception. Mechanism: converts sound into electrical signals that stimulate the auditory nerve. MedlinePlus

12. Low-vision care.
    Optical aids, contrast-rich environments, and orientation-mobility training. Purpose: maximize usable vision and safety. Mechanism: environmental and device adaptations offset retinal dysfunction. MedlinePlus

13. Seizure-safety planning.
    Home rescue plan, supervision during bathing, sleep positioning. Purpose: reduce injury and enable fast rescue medication use. Mechanism: environmental risk reduction plus timely intervention. MedlinePlus

14. Developmental/educational services.
    Early intervention and individualized education plans. Purpose: sustain cognitive, motor, and social skills. Mechanism: structured enrichment counters regression. MedlinePlus

15. Cardiac monitoring (if cardiomyopathy risk).
    Scheduled cardiology follow-up. Purpose: detect and manage heart muscle weakness early. Mechanism: echocardiography identifies dysfunction for timely therapy. MedlinePlus

16. Respiratory hygiene & aspiration prevention.
    Airway clearance and reflux management. Purpose: lower pneumonia risk. Mechanism: reduces aspiration and mucus stasis. PubMed

17. Genetic counseling for family planning.
    Explains X-linked inheritance and testing options. Purpose: informed reproductive choices. Mechanism: risk estimation and carrier testing. MedlinePlus

18. Vaccination per schedule.
    Routine immunizations help prevent infections that can trigger crises. Purpose: avoid catabolic illnesses. Mechanism: immune priming lowers severe infection risk. PubMed Central

19. Palliative/supportive care integration.
    Symptom control, goals-of-care planning. Purpose: improve quality of life for child and family. Mechanism: coordinated symptom relief and psychosocial support. orpha.net

20. Clinical-trial awareness.
    Discuss research options as they emerge. Purpose: access to novel approaches. Mechanism: experimental strategies targeting mitochondrial function may be studied. orpha.net

Drug treatments

Important: Many medicines below are used off-label in this disease and must be individualized by a metabolic specialist. Doses are general label ranges, not personal advice.

1. Levocarnitine (Carnitor®).
   Class/Purpose: carnitine supplement; supports detoxification of acyl groups and replenishes free carnitine pools. Dose/Time: commonly 50–100 mg/kg/day divided (oral) in pediatric metabolic settings; IV options exist during crises (per label, dosing varies by indication). Mechanism: shuttles acyl groups to form acylcarnitines that can be excreted, supporting energy metabolism. Side effects: GI upset, fishy odor; caution in renal impairment. FDA Access Data

2. Levetiracetam (IV/PO).
   Class/Purpose: antiepileptic for seizures. Dose: pediatric maintenance often ~20–60 mg/kg/day divided; IV loading used acutely per label/clinical protocols. Mechanism: modulates synaptic vesicle protein SV2A to reduce neuronal hyperexcitability. Side effects: somnolence, irritability; adjust in renal impairment. FDA Access Data

3. Clobazam (Onfi®).
   Class/Purpose: benzodiazepine adjunct for refractory seizures. Dose: weight-based; start low and titrate per label. Mechanism: GABA-A positive allosteric modulator increases inhibitory signaling. Side effects: sedation, drooling, behavior changes; withdrawal risk if abruptly stopped. FDA Access Data

4. Diazepam rectal gel (Diastat®) / injectable diazepam.
   Purpose: home/ED rescue for seizure clusters or status. Dose: weight-based rectal dosing or IV per label. Mechanism: GABA-A potentiation. Side effects: respiratory depression, sedation—use with monitoring. FDA Access Data

5. Midazolam (IM/IN/IV).
   Purpose: emergency control of status epilepticus when IV access is limited. Dose: per label (e.g., IM 10 mg in adults; pediatric weight-based). Mechanism: GABA-A potentiation. Side effects: respiratory depression; airway readiness required. FDA Access Data

6. Phenobarbital (Sezaby® – neonatal/infant seizures).
   Purpose: first-line in neonates; sometimes used later if needed. Dose: label-guided loading/maintenance in mg/kg. Mechanism: prolonged GABA-mediated chloride currents. Side effects: sedation, respiratory depression, hypotension; drug interactions. FDA Access Data

7. Topiramate.
   Purpose: adjunct for epilepsy and migraines. Dose: weight-based titration per label. Mechanism: multiple (sodium channels, GABA, AMPA/kainate). Side effects: appetite loss, acidosis risk (carbonic anhydrase inhibition), kidney stones—monitor bicarbonate. FDA Access Data

8. **Valproate (Depakote®/Depacon®) — generally avoid/caution in mitochondrial disease.
   Purpose: antiepileptic; BUT FDA labels warn it is contraindicated in patients with POLG-related mitochondrial disorders and in children <2 y suspected of mitochondrial disease due to risk of fatal hepatotoxicity; many experts avoid it broadly in mitochondrial epilepsies. Mechanism: increases GABA; multiple actions. Side effects: hepatotoxicity, pancreatitis, thrombocytopenia, teratogenicity. FDA Access Data+2FDA Access Data+2

9. Ondansetron (IV/PO).
   Purpose: antiemetic during intercurrent illness to maintain oral intake. Dose: weight-based per label. Mechanism: 5-HT3 receptor antagonism. Side effects: QT prolongation risk; constipation. FDA Access Data

10. Sodium bicarbonate (IV).
    Purpose: correction of severe metabolic acidosis under specialist guidance. Dose: individualized per blood gases; see label cautions. Mechanism: buffers hydrogen ions, raises serum bicarbonate. Side effects: fluid overload, hypernatremia, shifts in potassium. FDA Access Data

11. Dextrose 10% infusion (D10W).
    Purpose: provides rapid calories and treats hypoglycemia in crises. Dose: rate per weight and metabolic protocol. Mechanism: exogenous glucose suppresses catabolism. Side effects: hyperglycemia, fluid shifts—monitor electrolytes. FDA Access Data

12. Arginine hydrochloride (IV).
    Purpose: ammonia control in specific settings; standard in urea-cycle disorders—off-label if used for hyperammonemia outside UCDs. Dose: label-based in UCD; specialist use only. Mechanism: provides urea-cycle substrate to enhance ammonia clearance. Side effects: hyperkalemia, acidosis risk—intensive monitoring. FDA Access Data

13. Sodium phenylacetate/sodium benzoate (AMMONUL®).
    Purpose: ammonia scavenger in UCDs; sometimes considered off-label in extreme hyperammonemia while diagnosis evolves. Dose: weight-based per label. Mechanism: alternative pathway conjugation of nitrogen to phenylacetylglutamine/hippurate for renal excretion. Side effects: metabolic acidosis, hypokalemia, fluid overload; ICU use. FDA Access Data

14. Intrathecal baclofen (for severe spasticity).
    Purpose: reduce tone/comfort in advanced neurologic impairment. Dose: pump-delivered per label after screening dose. Mechanism: spinal GABA-B agonism. Side effects: overdose/withdrawal risks; pump maintenance essential. FDA Access Data

15. Clonazepam.
    Purpose: adjunct for myoclonus/epilepsy. Dose: start low, titrate per label. Mechanism: GABA-A potentiation. Side effects: sedation, dependence, respiratory depression. FDA Access Data

16. Phenytoin (IV/PO).
    Purpose: second-line for status/generalized seizures when selected by neurology. Dose: mg/kg loading/maintenance per label. Mechanism: voltage-gated sodium channel blockade. Side effects: arrhythmia (IV), gingival hyperplasia, drug interactions; monitor levels. FDA Access Data

17. Midazolam nasally/buccally for home rescue (formulation-dependent).
    Purpose: caregiver-administered seizure rescue where available. Dose: per product label. Mechanism: rapid GABA-A effect. Side effects: sedation/respiratory risk—caregiver training needed. FDA Access Data

18. IV fluids (0.9% sodium chloride) as vehicle/rehydration.
    Purpose: support circulation and deliver dextrose/electrolytes per protocol. Dose: weight-based maintenance/bolus. Mechanism: restores volume and electrolyte balance. Side effects: fluid overload, hypernatremia. FDA Access Data

19. Antipyretics (e.g., acetaminophen).
    Purpose: fever control to limit catabolic stress and improve intake. Dose: per pediatric label. Mechanism: central COX inhibition reduces fever. Side effects: liver dose limits—avoid duplication. FDA Access Data

20. Topical or enteral acid suppressants for severe reflux (specialist-guided).
    Purpose: reduce reflux-related aspiration risk. Mechanism: lower gastric acidity/volume. Side effects: infection/nutrient risks with long-term use; weigh benefits. (Label sources vary by product; use per local formulary and pediatric guidance.) MedlinePlus

Dietary molecular supplements

1. L-Carnitine. Supports mitochondrial fatty-acid transport and removal of toxic acyl groups; sometimes used alongside levocarnitine Rx to maintain stores. Typical supplemental intakes vary; high doses can cause GI upset. Mechanistic rationale is energy support and detoxification, but clinical benefit in HSD10 disease is unproven. Office of Dietary Supplements+1

2. Riboflavin (Vitamin B2). Mitochondrial flavoprotein cofactor; occasionally trialed in acyl-CoA dehydrogenase defects. Doses vary in practice; excess turns urine bright yellow. Evidence for HSD10 disease is limited. Office of Dietary Supplements

3. Thiamine (Vitamin B1). Coenzyme in carbohydrate metabolism that supports energy pathways during illness recovery; dosing individualized; avoid over-supplementation without need. Office of Dietary Supplements

4. Biotin (Vitamin B7). Carboxylase cofactor (propionyl-CoA, etc.); widely used in organic acidemias where responsive, but no proof of disease modification in HSD10. Be aware of biotin-lab assay interference. Office of Dietary Supplements

5. Coenzyme Q10. Electron-transport chain cofactor and antioxidant; sometimes considered for mitochondrial support although data are mixed; dosing varies. NCCIH+1

6. Omega-3 fatty acids. General anti-inflammatory and neuroprotective interest; may support cardiometabolic health; use food-first approach. Evidence specific to HSD10 disease is lacking. Office of Dietary Supplements

7. Vitamin D. Bone/immune health; monitor levels and supplement if deficient, especially in children with limited mobility or feeding issues. Office of Dietary Supplements

8. Magnesium. Cofactor for many enzymes; correct deficiency if present to support neuromuscular function; excessive dosing can cause diarrhea. Office of Dietary Supplements

9. Multivitamin/mineral (age-appropriate). Helps cover gaps in restrictive or illness-prone feeding patterns; choose products evaluated for quality. Office of Dietary Supplements

10. Creatine. Energy buffer for muscle/brain; limited pediatric mitochondrial data; only under specialist oversight due to dose-related GI effects. Office of Dietary Supplements

Drugs, immunity-booster / regenerative / stem-cell

There are no FDA-approved “immunity-boosting,” regenerative, or stem-cell drugs for HSD10 disease. Management is supportive; experimental strategies remain research-stage. Families should prioritize routine vaccines and infection prevention and discuss trials with a metabolic center. orpha.net+1

• Example (preventive biologics): Nirsevimab or Palivizumab may be considered by pediatricians for RSV prevention in eligible infants to reduce severe infection burden; these are not disease-specific treatments. FDA Access Data+1

Surgeries

1. Gastrostomy tube (PEG/G-tube).
   Procedure: endoscopic or surgical placement of a tube into the stomach. Why: reliable nutrition/hydration/medication delivery when swallowing is unsafe or inadequate. MedlinePlus

2. Nissen fundoplication (selected cases).
   Procedure: wrap of upper stomach around lower esophagus. Why: reduce severe reflux and aspiration when medical therapy fails in neurologically impaired children. PubMed

3. Cochlear implant.
   Procedure: implant internal electrode with external sound processor. Why: provide auditory input in severe sensorineural hearing loss to support language. MedlinePlus

4. Intrathecal baclofen pump placement.
   Procedure: implant programmable pump/catheter to spinal canal. Why: treat severe spasticity unresponsive to oral therapy; improves comfort and care. FDA Access Data

5. Orthopedic soft-tissue procedures (e.g., tendon lengthening).
   Procedure: surgical release/lengthening to relieve fixed contractures. Why: improve positioning, ease care, and reduce pain in advanced motor impairment. MedlinePlus

Preventions

1. Avoid prolonged fasting; keep steady carbs and fluids. PubMed Central

2. Treat infections early; follow sick-day plan and seek care for vomiting/poor intake. PubMed Central

3. Keep vaccinations up to date to lower severe illness risk. PubMed Central

4. Have an emergency letter and supplies (glucometer, oral rehydration, rescue meds). orpha.net

5. Avoid unnecessary high-protein or ketogenic diets unless specialist-directed. NCBI

6. Avoid valproate in suspected mitochondrial disease; confirm choices with neurology. FDA Access Data

7. Plan anesthesia carefully with metabolic team (e.g., avoid lactated Ringer’s in organic acidemias). NCBI

8. Monitor growth and nutrition with a metabolic dietitian. SpringerLink

9. Schedule regular neuro/vision/hearing/cardiac follow-up. MedlinePlus

10. Discuss trials and registries with your center. orpha.net

When to see doctors (red flags)

Seek urgent care for fever with poor intake, repeated vomiting, lethargy, rapid breathing, seizures, hypoglycemia signs (sweating, shakiness, confusion), or regression of skills. These can signal metabolic decompensation needing IV glucose and specialist protocols. PubMed Central

Foods/feeding patterns

• Eat: small, frequent carbohydrate-containing meals/snacks (e.g., grains, fruits, milk if tolerated) to prevent fasting; adequate calories for growth. PubMed Central

• Eat: balanced protein per dietitian—enough for growth, not excessive; medical formulas only if prescribed. SpringerLink

• Eat: fluids generously during illness; use oral rehydration solutions if advised. PubMed Central

• Eat: micronutrient-rich foods (fruits/vegetables, fortified staples); supplement deficiencies under care. Office of Dietary Supplements

• Avoid: skipping meals/overnight fasts (consider bedtime snack or continuous feeds if recommended). PubMed Central

• Avoid: very high-protein or ketogenic diets unless your metabolic team prescribes them. NCBI

• Avoid: unregulated “mitochondrial boosters” without clinician oversight. orpha.net

• Avoid: excessive biotin near lab testing (can distort some assays). Office of Dietary Supplements

• Avoid: energy drinks/herbal stimulants during illness (dehydration, appetite loss). Office of Dietary Supplements

• Avoid: any diet changes without your metabolic clinic—plans must be individualized. SpringerLink

FAQs

1. Is there a cure?
   No proven disease-modifying therapy exists; care is supportive and crisis-prevention focused. SpringerLink

2. Why is it worse in boys?
   The gene is on the X chromosome; males (one X) are typically more severely affected than females (two Xs). MedlinePlus

3. What causes the abnormal acids?
   HSD17B10 enzyme dysfunction blocks a step in isoleucine breakdown, raising 2-methyl-3-hydroxybutyric acid and tiglylglycine. PubMed Central

4. How is it diagnosed?
   Clinical picture + urine organic acids/acylglycines, acylcarnitine profile, and HSD17B10 genetic testing; some screens can detect related markers. Nature

5. Do special diets help?
   Routine isoleucine restriction has not shown clear clinical benefit; any diet change must be specialist-guided to avoid malnutrition. SpringerLink

6. What triggers crises?
   Fasting, infections, and dehydration; avoid catabolism with early glucose and fluids. PubMed Central

7. Which seizure medicines are preferred?
   Choices are individualized; levetiracetam, clobazam, and rescue benzodiazepines are commonly used; valproate is generally avoided in mitochondrial disease contexts. FDA Access Data+2FDA Access Data+2

8. Are supplements necessary?
   Only if a clinician recommends them; evidence in HSD10 disease is limited. Office of Dietary Supplements

9. Can hearing/vision be supported?
   Yes—hearing aids/cochlear implants and low-vision services may help. MedlinePlus

10. Is the heart affected?
    Cardiomyopathy can occur; routine cardiology checks are advised. MedlinePlus

11. What about anesthesia/surgery?
    Plan ahead with metabolic and anesthesia teams; avoid catabolism and certain fluids (e.g., lactated Ringer’s in organic acidemias). NCBI

12. Are stem-cell or gene therapies available?
    Not at this time; discuss trials with your center. orpha.net

13. Can my other children be tested?
    Genetic counseling can discuss carrier and predictive testing options. MedlinePlus

14. What specialists should follow my child?
    Metabolic genetics, neurology, dietetics, cardiology, audiology/ophthalmology, rehab, and palliative/supportive care. orpha.net

15. Where can I read more?
    Orphanet, MedlinePlus Genetics, GARD, and peer-reviewed reviews are reliable starting points. orpha.net+2MedlinePlus+2

Disclaimer: Each person’s journey is unique, treatment plan, life style, food habit, hormonal condition, immune system, chronic disease condition, geological location, weather and previous medical  history is also unique. So always seek the best advice from a qualified medical professional or health care provider before trying any treatments to ensure to find out the best plan for you. This guide is for general information and educational purposes only. Regular check-ups and awareness can help to manage and prevent complications associated with these diseases conditions. If you or someone are suffering from this disease condition bookmark this website or share with someone who might find it useful! Boost your knowledge and stay ahead in your health journey. We always try to ensure that the content is regularly updated to reflect the latest medical research and treatment options. Thank you for giving your valuable time to read the article.

The article is written by Team RxHarun and reviewed by the Rx Editorial Board Members

Last Updated: October 23, 2025.

Previous

Beta-Ketothiolase Deficiency

Next

3-Methyl-3-Hydroxybutyric Acidemia

Related Articles

Added to wishlistRemoved from wishlist 0

Congenital Epstein–Barr Virus Infection

Added to wishlistRemoved from wishlist 0

Mother-to-Child Transmission of Enterovirus Infection

Added to wishlistRemoved from wishlist 0

Congenital Enterovirus Infectious Disease

Added to wishlistRemoved from wishlist 0

Congenital Enterovirus Infection